Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Despite the increasing prevalence of heart failure with preserved left ventricular function, there are no specific treatments, partially because the mechanism of impaired relaxation is incompletely understood. Evidence indicates that cardiac relaxation may depend on nitric oxide (NO), generated by NO synthase (NOS) requiring the co-factor tetrahydrobiopterin (BH4). Recently, we reported that hypertension-induced diastolic dysfunction was accompanied by cardiac BH4 depletion, NOS uncoupling, a depression in myofilament cross-bridge kinetics, and S-glutathionylation of myosin binding protein C (MyBP-C). We hypothesized that the mechanism by which BH4 ameliorates diastolic dysfunction is by preventing glutathionylation of MyBP-C and thus reversing changes of myofilament properties that occur during diastolic dysfunction. We used the deoxycorticosterone acetate (DOCA)-salt mouse model, which demonstrates mild hypertension, myocardial oxidative stress, and diastolic dysfunction. Mice were divided into two groups that received control diet and two groups that received BH4 supplement for 7 days after developing diastolic dysfunction at post-operative day 11. Mice were assessed by echocardiography. Left ventricular papillary detergent-extracted fiber bundles were isolated for simultaneous determination of force and ATPase activity. Sarcomeric protein glutathionylation was assessed by immunoblotting. DOCA-salt mice exhibited diastolic dysfunction that was reversed after BH4 treatment. Diastolic sarcomere length (DOCA-salt 1.70±0.01 vs. DOCA-salt+BH4 1.77±0.01 μm, P<0.001) and relengthening (relaxation constant, τ, DOCA-salt 0.28±0.02 vs. DOCA-salt+BH4 0.08±0.01, P<0.001) were also restored to control by BH4 treatment. pCa50 for tension increased in DOCA-salt compared to sham but reverted to sham levels after BH4 treatment. Maximum ATPase rate and tension cost (ΔATPase/ΔTension) decreased in DOCA-salt compared to sham, but increased after BH4 treatment. Cardiac MyBP-C glutathionylation increased in DOCA-salt compared to sham, but decreased with BH4 treatment. MyBP-C glutathionylation correlated with the presence of diastolic dysfunction. Our results suggest that by depressing S-glutathionylation of MyBP-C, BH4 ameliorates diastolic dysfunction by reversing a decrease in cross-bridge turnover kinetics. These data provide evidence for modulation of cardiac relaxation by post-translational modification of myofilament proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Landmesser, U., Dikalov, S., Price, S. R., McCann, L., Fukai, T., Holland, S. M., Mitch, W. E., & Harrison, D. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200314172 · Cited by 1,660
Cited by
Inflammation and fibrosis in murine models of heart failure
Bacmeister, L., Schwarzl, M., Warnke, S., Stoffers, B., Blankenberg, S., Westermann, D., & Lindner, D. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-019-0722-5 · Cited by 382
Pre-Clinical Diastolic Dysfunction
Wan, S.-H., Vogel, M. W., & Chen, H. H. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.063 · Cited by 327
Murine Models of Heart Failure With Preserved Ejection Fraction
Valero-Muñoz, M., Backman, W., & Sam, F. (2017) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2017.07.013 · Cited by 206
“DOCA-salt mice show diastolic dysfunction with preserved systolic function (109,111,112) accompanied by exercise intolerance, but without pulmonary congestion or HF (113).”
BackgroundWithaar, C., Lam, C. S. P., Schiattarella, G. G., de Boer, R. A., & Meems, L. M. G. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab389 · Cited by 150
“remains preserved while moderate diastolic dysfunction can be observed.(180) Nevertheless, these mice do not display lung congestion.”
BackgroundJeong, E., Chung, J., Liu, H., Go, Y., Gladstein, S., Farzaneh‐Far, A., Lewandowski, E. D., & Dudley, S. C. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003046 · Cited by 119
“Administration of tetrahydrobiopterin (BH4), a cofactor of nitric oxide synthase (NOS), can prevent S-glutathionylation of cMyBP-C and diastolic dysfunction.(6) Furthermore, we have shown that other conditions that can increase oxidative stress in cardiomyocytes, such as angiotensin II exposure and mitochondrial manga…”
BackgroundMethodInfluentialSelf-citationPhosphorylation of cardiac Myosin-binding protein-C is a critical mediator of diastolic function
Rosas, P. C., Liu, Y., Abdalla, M. I., Thomas, C. M., Kidwell, D. T., Dusio, G. F., Mukhopadhyay, D., Kumar, R., Baker, K. M., Mitchell, B. M., et al. (2015) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001550 · Cited by 112
“For example, a hypertensive mouse model exhibited both diastolic dysfunction and decreased cMyBP-C phosphorylation at Ser282.(37) A review(17) has summarized that essentially, all genetically modified mouse models of cMyBP-C dephosphorylation exhibit some form of diastolic dysfunction.”
Self-citationSignaling by S-nitrosylation in the heart
Murphy, E., Kohr, M., Menazza, S., Nguyen, T., Evangelista, A., Sun, J., & Steenbergen, C. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.01.003 · Cited by 82
Metadata
- Authors
- Jeong, E.-M., Monasky, M. M., Gu, L., Taglieri, D. M., Patel, B. G., Liu, H., Wang, Q., Greener, I., Dudley, S. C., & Solaro, R. J.
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 56
- Pages
- 44-54
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2088374043
- Cited by
- 84
- References
- 1
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.